-
WSP-5 for Live-Cell H2S Imaging
2026-09-02
WSP-5 converts transient hydrogen sulfide exposure into a rapid green fluorescent signal, giving researchers spatial and temporal information that bulk sulfide assays can miss. This guide translates diabetic cardiomyopathy findings into practical workflows for donor testing, lipotoxicity models, and cancer cell model imaging.
-
DAMGO Workflows for µ-Opioid Receptor Research
2026-09-01
DAMGO links receptor-proximal assays with circuit-level studies of opioid-induced mechanical hypersensitivity and tolerance. This practical guide shows how to use a selective µ-opioid receptor agonist in membrane signaling, ex vivo tissue, and mouse pain-circuit workflows while avoiding common interpretation errors.
-
Nutlin-3a: MDM2 Inhibitor Mechanism & Uses
2026-09-01
Nutlin-3a is a small-molecule MDM2 inhibitor that occupies the TP53-binding pocket and supports p53 pathway activation. It is a research tool for studying cell cycle arrest, apoptosis induction, and genotype-dependent responses in cancer models.
-
MLN4924 Workflow for Neddylation Research
2026-08-31
MLN4924 provides a selective way to interrogate NAE-dependent protein degradation, from rapid cullin target engagement to cell-cycle and tumor-model phenotypes. Its use as a pathway perturbation tool also enables mechanistic testing of the DCAF7–CRL4B antiviral axis, while highlighting why context and assay timing matter.
-
Bovine Insulin for Stress-Aware Cell Culture
2026-08-31
Bovine insulin is more than a routine media supplement: it is a controllable metabolic variable in reproducible cell culture. This guide connects insulin from bovine pancreas with ER-stress-aware assay design, using recent HBV–HMGB1 research to sharpen interpretation without overstating translational evidence.
-
Metformin Hydrochloride in AMPK Fibrosis Research
2026-08-30
Metformin Hydrochloride is a practical tool for connecting metabolic regulation with tissue remodeling. This workflow translates rabbit vocal fold fibrosis findings into assay-ready choices for AMPK, TGF-β, collagen, and glucose-metabolism studies while highlighting controls and reproducibility limits.
-
QPRT, P2Y11, and Breast Cancer Invasion
2026-08-29
The reference study identifies quinolinate phosphoribosyltransferase (QPRT) as a driver of breast cancer cell migration and invasion, linking altered NAD+ metabolism to myosin light chain phosphorylation and purinergic signaling. Its genetic and pharmacological experiments position P2Y11-linked signaling as a mechanistic research target, while also showing why the findings require validation across tumor models and clinical cohorts.
-
miR-18a–ALOXE3 Axis in Glioblastoma
2026-08-28
Yang et al. identify a miR-18a–ALOXE3 regulatory axis that links lipid metabolism to ferroptosis resistance and glioblastoma-cell migration. Their human-tumor analyses, cellular perturbations, lipid mediator studies, and orthotopic models support ALOXE3 as a mechanistic tumor suppressor rather than merely a disease-associated marker.
-
RNAi Screen Reveals SARS-CoV-2 Release Factors
2026-08-28
Kerr et al. developed an arrayed, druggable-genome RNA interference screen that measured SARS-CoV-2 production at multiple stages of the replication and reinfection cycle. The study identifies Rab11a-linked vesicular transport as a conserved proviral pathway and shows that CDK9 inhibition can block viral release, while also clarifying the experimental limits of host-targeted antiviral interpretation.
-
I-BET151 Workflows for Cancer Research
2026-08-27
I-BET151 (GSK1210151A) offers a practical way to probe BRD2, BRD3, and BRD4-dependent transcription in cancer models. This guide connects BET inhibition with apoptosis, cell cycle, chromatin, and prostate cancer disulfidptosis workflows while emphasizing controls, solvent handling, and interpretation limits.
-
SNS-032: CDK Biology from Cancer to Virology
2026-08-27
SNS-032 (BMS-387032) links selective CDK2, CDK7, and CDK9 inhibition with measurable changes in cell-cycle and transcriptional signaling. This article develops an assay-centered framework that distinguishes direct kinase effects from downstream transcriptional collapse and evaluates what SARS-CoV-2 host-factor research can—and cannot—add to cancer studies.
-
Gastric Cancer Assembloids Add Patient-Matched Stroma
2026-08-26
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with matched stromal subpopulations, including fibroblast, endothelial, and mesenchymal cell populations. The model altered gene-expression profiles and drug responses relative to organoid monocultures, providing a more physiologically relevant platform for studying tumor–stroma interactions and treatment resistance.
-
Cistanche Nanovesicles Relieve Sertoli Cell Arrest
2026-08-26
A version 1 reference study reports that Cistanche deserticola exosome-like nanovesicles protect against cyclophosphamide-associated testicular injury by delivering miR159b-3p to Sertoli cells and suppressing the cell-cycle inhibitor P21. The work connects nanovesicle uptake through heparan sulfate proteoglycans with restoration of CDK1 activity, providing a mechanistic basis for further preclinical investigation of male reproductive toxicity.
-
DiscoveryProbe FDA-approved Drug Library for AML
2026-08-25
Use a clinically familiar compound collection to move from AML viability hits to mechanism-resolved PANoptosis assays. The DiscoveryProbe FDA-approved Drug Library supports efficient drug repositioning screening, orthogonal validation, and target-focused follow-up with ready-to-use DMSO stocks.
-
Lanabecestat (AZD3293) in BACE1 Workflows
2026-08-25
Lanabecestat (AZD3293) enables controlled BACE1 enzyme inhibition for linking amyloid-beta production inhibition with neuronal function assays. This practical guide outlines dose-ranging, medium-based amyloid measurements, optical electrophysiology, and troubleshooting strategies for Alzheimer’s disease research.